Jessica Donington, MD, and Christine Bestvina, MD, join host Erin Gillaspie, MD, to unpack key lung cancer advances from ESMO 2025, including adjuvant ALK inhibition (ALINA, ELEVATE), perioperative immunotherapy (KEYNOTE-671), and the expanding neoadjuvant space in borderline resectable disease.

In this STS blog article, Shubham Gulati, a third-year medical student at the Icahn School of Medicine at Mount Sinai, reflects on a transformative year with his mentor, Dr. Ravi Rajaram, and other accomplished surgeons, who created space for candid discussions about the realities and rewards of becoming a cardiothoracic surgeon.

In this special edition of the Best Science in Lung Cancer series, host Erin Gillaspie, MD, speaks with Paula Ugalde, MD, to examine findings from ELCC, including restaging in the neoadjuvant era, redefining resectability, the use of AI in multidisciplinary precision care, and the current de-escalation debate.

In this special edition of the Best Science in Lung Cancer series, host Erin Gillaspie, MD, sits down with Brendon Stiles, MD, to discuss insights from ASCO, including perioperative immunotherapy, CheckMate 816, and expanding surgical boundaries.

In this special edition of the Best Science in Lung Cancer series, Leah Backhus, MD, joins host Erin Gillaspie, MD, to explore key takeaways from WCLC, including how precision data, surgical restraint, and breakthrough immunotherapy are transforming care.

The latest episode of Thinking Thoracic dives into one of the most challenging diseases in thoracic oncology—malignant pleural mesothelioma. Host Erin Gillaspie, MD, speaks with Joshua Reuss, MD, a thoracic medical oncologist and clinical trials leader, about how immunotherapy, evolving surgical strategies, and global practice patterns are reshaping care for this rare cancer.

The episode covers the impact of the Checkmate 743 trial, controversy surrounding the MARS-2 surgical study, promising results from neoadjuvant immunotherapy trials, and the critical need for collaboration and clinical trial enrollment to drive progress.

Listen now to explore where mesothelioma research is headed and what it means for patient care.

The occupation we have chosen is the most fulfilling job in the world. Cardiothoracic surgery has been the only career I have pursued as an adult, but I know that even without a meaningful comparison, my bold claim is correct. We have studied and practiced for years to acquire skills so that we can help to cure our patients or at least minimize their suffering. Yet, throughout all of our careers, having a patient succumb to their disease, or our attempt at treating their disease, is as much of a certainty as our own eventual mortality. Read this blog by Dr. Derek Serna-Gallegos on how to face your first patient death as a cardiothoracic surgeon.

In this special episode of Same Surgeon, Different Light, hosts Dr. Cherie Erkmen and Dr. Sara Pereira sit down with STS President Dr. Joseph Sabik as he reflects on his early interest science, the mentors who shaped his career, and the pivotal role mentorship continues to play in his leadership within the Society.

He also shares insights into what attendees can anticipate at the 62nd STS Annual Meeting, unpacks the meaning behind this year’s theme—“Teaching for Tomorrow Together”—and offers an exclusive preview of the inspiring speakers and events that will celebrate the specialty’s future.

In this episode of Thinking Thoracic, host Dr. Erin Gillaspie talks with Dr. Robert Lentz and Dr. Fabien Maldonado about the groundbreaking VERITAS trial, which is reshaping how clinicians diagnose lung cancer. Published in the New England Journal of Medicine, the VERITAS trial compared navigational bronchoscopy with CT-guided biopsy in a rigorous, randomized design, bringing much-needed evidence to interventional pulmonology. The discussion explores how the study was conceived, why robust device trials are vital to patient outcomes, and what the findings mean for the future of minimally invasive lung diagnostics.

Whether you are a thoracic surgeon and you are going to break through the ceiling on survival for mesothelioma, an adult cardiac surgeon tackling structural valve deterioration, or a community cardiothoracic surgeon improving outcomes for ECMO patients, identifying and building a niche is exciting and rewarding. In this blog article, hear from Dr. Brian Bateson on how you can successfully build a niche with care, passion, and understanding.